Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ilett, K.F.
Right arrow Articles by Kadlubar, F.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilett, K.F.
Right arrow Articles by Kadlubar, F.F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 Oxford University Press

research-article

Distribution of acetyltransferase activities in the intestines of rapid and slow acetylator rabbits

K.F. Ilett, P.T. Reeves, R.F. Minchin, B.F. Kinnear, H.F. Watson and F.F. Kadlubar 1

Drug Matabolism and Toxicology Section, Department of Pharmacology, University of Western Australia Nedlands, 6009, Western Australia

1Visiting Fellow: National Center for Toxicological Research, Jefferson, AR, USA

Epidemiological studies have shown that there is a significantly greater proportion of the rapid acetylator phenotype in patients th colorectal tumors than in controls; phenotype-related differences in bioactivation of dietary or environmental amines in the intestinal epithelium have been suggested as a mechanism for this effect. In the present study, we have used hepatic and intestinal cytosols to compare N-acetyl-transferase (NAT1 and NAT2), O-acetyl-transferase (OAT) and arylhydroxamic acid N,O-acyltransferase (AHAT) distribution in rapid and slow acetylator rabbits. The ratio (rapid/slow) for p-aminobenzoic acid acetylatlon (a selective substrate for NAT1) was 6 in liver, 1.7–2 in small intestine and 1.3–1.5 in large intestine while the ratio of sulfamethazine acetylation (a selective substrate for NAT2) was 150 in liver, 16–22 in small intestine and 1.8–2.5 in large intestine. The ratios (rapid/slow) for DNA binding of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and N-hydroxy-4-aminobiphenyl (primarily substrates for OAT) were 82–84 in liver, 13–20 in small intestine and 3.8–5.3 in large intestine and for DNA binding of N-hydroxy-2-acetylamidofluorene (a substrate for ABAT), the ratio was 432 in liver, 32–161 in small intestine and 8.8–13.5 in large intestine. The data show also that NAT1 activity is uniformly distributed along the intestinal tract whereas NAT2 activity is highest in the small intestine. In addition, hepatic and intestinal OAT and AHAT but not NAT1 activities in the rabbit intestine are similarly distributed to activities for NAT2, suggesting that NAT2, OAT and AHAT activities are properties of a single protein in the rapid acetylator phenotype. Moreover, OAT and AHAT activities were much higher in tissues from the rapid than the slow phenotype. The data support the hypothesis that phenotype-dependent metabolic activation of N-OH heterocydlic or aromatic amines to reactive acetoxy metabolites may be involved in the etiology of colorectal cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
R. J. Delfino, R. Sinha, C. Smith, J. West, E. White, H. J. Lin, S.-Y. Liao, J. S.Y. Gim, H. L. Ma, J. Butler, et al.
Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype
Carcinogenesis, April 1, 2000; 21(4): 607 - 615.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K. F. Windmill, A. Gaedigk, P. de la M. Hall, H. Samaratunga, D. M. Grant, and M. E. McManus
Localization of N-Acetyltransferases NAT1 and NAT2 in Human Tissues
Toxicol. Sci., March 1, 2000; 54(1): 19 - 29.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. W. Hein, M. A. Doll, A. J. Fretland, M. A. Leff, S. J. Webb, G. H. Xiao, U.-S. Devanaboyina, N. A. Nangju, and Y. Feng
Molecular Genetics and Epidemiology of the NAT1 and NAT2 Acetylation Polymorphisms
Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 29 - 42.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
S. Y. Zhou, D. Fleisher, L. H. Pao, C. Li, B. Winward, and E. M. Zimmermann
Intestinal Metabolism and Transport of 5-Aminosalicylate
Drug Metab. Dispos., April 1, 1999; 27(4): 479 - 485.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.